Announcing the Shared Revenue Collaborative Model

Art in Giving raises funds for childhood cancer research by selling the fine arts. It combines the creativity and generosity of over 50 artists with the needs of talented cancer researchers. Our business model makes it possible to increase funds available for pediatric cancer research without compromising other philanthropies. The funds we target are business expenses allocated for facility management to adorn buildings and offices. We also target budgets allocated for gifts to recognize individuals such as guest speakers and board members and to reward executives and other employees.

Clients include Sanofi/Genzyme, Pfizer, Equity Office, Alexandria Real Estate Equities, Inc., BioMed Realty, Wells Fargo and Raymond James.

The idea behind the Shared Revenue Model is to engage other nonprofits to partner with Art in Giving in identifying opportunities to adorn offices and lobbies and to also benefit from the funds raised.

The model partners with all nonprofits that are committed to health initiatives, to cancer and/or to the wellbeing of children.

Hospitals, such as St Jude and Johns Hopkins and Foundations such as Childhood Cancer Foundation and The Lung Cancer Foundation, societies such as the American Cancer Society, and other nonprofit organizations committed to children, cancer research and other health initiatives have institutional donors such as Google, Bank of America, Staples, Novartis, etc. that may be in need of art for new or renovated buildings and offices.

If a nonprofit organization is aware of an office expansion by an institutional donor and the nonprofit feels confident about the donor’s commitment to cancer research, we ask that it considers introducing that donor to the gallery of Art in Giving for the potential acquisition for its building project.  All net revenues to the Foundation from the sale of the art will be equally shared with the nonprofit.

As an example, a biotech firm bought about $100,000 worth of art from Art in Giving for its facility. We engaged two of our curators and 10 of our artists in the project. Fifty percent ($50K) went to the artists whose art works have been selected and the other 50% went to the Foundation.

 If a nonprofit had introduced us to the biotech firm, it would receive 60% of what goes to the Foundation or, $30K.  

The model generates new funds for childhood cancer research and health initiatives above and beyond what currently exists for philanthropy. The model and value proposition converts traditional corporate expenditures to benefit philanthropic causes.  We would like to think that the Shared Revenue Model is a win-win for the non-profit and the Art in Giving Foundation.

For more information, please contact Eliane Markoff at 617 877 4230 or via esmarkoff@verizon.net.Thank you for collaborating.